DOCM — DocMorris AG Share Price
0.000.00%
Last trade - 00:00- CH₣962.17m
- CH₣1.16bn
- CH₣969.46m
- 53
- 33
- 85
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.23 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.99 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -11.19% | ||
| Return on Equity | -30.09% | ||
| Operating Margin | -7.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CH₣m | 1,355.54 | 1,476.93 | 1,726.5 | 930.97 | 969.46 | 1,188.47 | 1,610.91 | -4.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Directors
- Walter Oberhaensli CMG (63)
- Stefan Feuerstein NEC (65)
- Thomas Schneider NVC (66)
- Marcel Ziwica CFO (46)
- Bernd Gschaider COO (55)
- Walter Hess MGB (56)
- Emanuel Lorini MGB (44)
- David Maso MGB (50)
- Betul Unaran MGB (45)
- Volker Amelung NED (56)
- Tobias Hartmann NED (49)
- Christian Mielsch NED (59)
- Florian Seubert NED (47)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 6th, 1993
- Public Since
- July 6th, 2017
- No. of Shareholders
- 14,636
- No. of Employees
- 1,453
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- SIX Swiss Exchange
- Shares in Issue
- 11,762,455
- Address
- Walzmuehlestrasse 49, FRAUENFELD, 8500
- Web
- https://www.zurrosegroup.com/
- Phone
- +41 527240020
- Contact
- Daniel Grigat
- Auditors
- Ernst & Young AG
Upcoming Events for DOCM
Zur Rose Group AG Annual Shareholders Meeting
DocMorris AG at UBS Pan European Small and Mid-Cap Conference
DocMorris AG at Berenberg European Conference
Half Year 2024 DocMorris AG Earnings Call
Half Year 2024 DocMorris AG Earnings Release
DocMorris AG at UBS Best of Switzerland Conference
Q3 2024 DocMorris AG Trading Statement Release
Similar to DOCM
Villars Holding SA
SIX Swiss Exchange
FAQ
What is the DocMorris AG share price?
As of Today at 19:07 UTC, shares in DocMorris AG are trading at CH₣81.80. This share price information is delayed by 15 minutes.
How has the DocMorris AG share price performed this year?
Shares in DocMorris AG last closed at CH₣81.80 and the price had moved by +115.6% over the past 365 days. In terms of relative price strength the DocMorris AG share price has outperformed the FTSE Global All Cap Index by +102.41% over the past year.
What are the analyst and broker recommendations for DocMorris AG?
The overall consensus recommendation for DocMorris AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the DocMorris AG dividend yield?
DocMorris AG does not currently pay a dividend.
Does DocMorris AG pay a dividend?
DocMorris AG does not currently pay a dividend.
When does DocMorris AG next pay dividends?
DocMorris AG does not currently pay a dividend.
How do I buy DocMorris AG shares?
To buy shares in DocMorris AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DocMorris AG?
As of the previous close price of CH₣81.80, shares in DocMorris AG had a market capitalisation of CH₣962.17m.
Where are DocMorris AG shares listed?
Here are the trading details for DocMorris AG:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: DOCM
What kind of share is DocMorris AG?
Based on an overall assessment of its quality, value and momentum DocMorris AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DocMorris AG share price forecast for 2024?
The analyst consensus target price for shares in DocMorris AG is CH₣98.72. That is 20.68% above the last closing price of CH₣81.80.
Analysts covering DocMorris AG currently have a consensus Earnings Per Share (EPS) forecast of -CH₣6.27 for the next financial year.
What is the trend in the DocMorris AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DocMorris AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +92.73%.
As of the last closing price of CH₣81.80, shares in DocMorris AG were trading +26.64% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DocMorris AG PE Ratio?
The DocMorris AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CH₣81.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DocMorris AG?
DocMorris AG's management team is headed by:
- Walter Oberhaensli - CMG
- Stefan Feuerstein - NEC
- Thomas Schneider - NVC
- Marcel Ziwica - CFO
- Bernd Gschaider - COO
- Walter Hess - MGB
- Emanuel Lorini - MGB
- David Maso - MGB
- Betul Unaran - MGB
- Volker Amelung - NED
- Tobias Hartmann - NED
- Christian Mielsch - NED
- Florian Seubert - NED